You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 21, 2025

Details for Patent: 10,709,674


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,709,674 protect, and when does it expire?

Patent 10,709,674 protects EPIDIOLEX and is included in one NDA.

This patent has thirty-six patent family members in twenty-one countries.

Summary for Patent: 10,709,674
Title:Use of cannabinoids in the treatment of epilepsy
Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures. In particular the CBD appears particularly effective in reducing atonic seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; Aicardi syndrome; CDKL5 and Dup15q in comparison to other seizure types. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
Inventor(s): Guy; Geoffrey (London, GB), Wright; Stephen (London, GB), Devinsky; Orrin (New York, NY)
Assignee: GW Research Limited (Cambridge, GB)
Application Number:16/678,961
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,709,674: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the intellectual property landscape effectively. This article will delve into the details of United States Patent 10,709,674, focusing on its scope, claims, and the broader patent landscape.

Overview of the Patent

Patent Title and Number

United States Patent 10,709,674, titled "Use of cannabinoids in the treatment of epilepsy," is a significant patent in the field of medical research and pharmaceuticals[5].

Inventors and Assignees

The patent lists the inventors and assignees involved in the development of this technology. Understanding who is behind the patent can provide insights into the potential applications and the entities that hold the intellectual property rights.

Scope of the Patent

Background and Summary

The patent describes the use of cannabinoids, specifically cannabidiol (CBD), in the treatment of epilepsy. It outlines the background of epilepsy, the current treatments, and how cannabinoids can offer a novel therapeutic approach. The summary section provides a concise overview of the invention, including the methods and compositions claimed[5].

Detailed Description

The detailed description section elaborates on the invention, including the chemical structures of the cannabinoids, the methods of administration, and the clinical trials or studies that support the efficacy of the treatment. This section is critical for understanding the technical aspects of the patent.

Claims of the Patent

Independent and Dependent Claims

The claims section is the heart of any patent, as it defines the scope of the invention. United States Patent 10,709,674 includes both independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations to the independent claims[5].

Claim Analysis

Analyzing the claims involves identifying the key elements, such as the active ingredients, the method of treatment, and any specific dosages or administration methods. For example, Claim 1 might broadly cover the use of CBD for treating epilepsy, while dependent claims might specify particular dosages or patient populations.

Patent Landscape

Prior Art and Related Patents

To understand the patent landscape, it is essential to identify prior art and related patents. Tools like the USPTO's Patent Public Search and the Common Citation Document (CCD) can help in identifying prior art cited by various patent offices, ensuring that the patent in question does not infringe on existing patents[1].

Global Patent Family

Using resources like the Global Dossier, one can identify the patent family for a specific application, including all related applications filed at participating IP Offices. This helps in understanding the global reach and protection of the patent[1].

Searching and Analyzing Patents

USPTO Resources

The USPTO provides several resources for searching and analyzing patents, including the Patent Public Search tool, which offers modern interfaces for enhanced access to prior art. The Public Search Facility and Patent and Trademark Resource Centers (PTRCs) also offer assistance in conducting thorough patent searches[1].

International Patent Databases

To ensure global coverage, one must also search international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Economic and Legal Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide insights into the economic and legal implications of patent claims. This dataset includes detailed information on claims from U.S. patents and applications, which can help in understanding the scope and impact of the patent[3].

Small Claims Patent Court

The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could have significant implications for the enforcement and litigation of patents like 10,709,674. This court could provide a more accessible and cost-effective way to resolve patent disputes[2].

Key Takeaways

  • Understanding the Scope: The scope of the patent defines what is protected and what is not. For United States Patent 10,709,674, this includes the specific use of cannabinoids in treating epilepsy.
  • Claims Analysis: The claims section is crucial and must be carefully analyzed to understand the breadth and limitations of the patent.
  • Patent Landscape: Identifying prior art and related patents is essential to avoid infringement and understand the global protection of the patent.
  • Resources: Utilizing USPTO resources and international patent databases is vital for comprehensive patent analysis.
  • Economic and Legal Implications: Understanding the economic and legal context, including potential litigation pathways, is important for managing and enforcing the patent.

FAQs

Q: How do I search for prior art related to United States Patent 10,709,674?

A: You can use the USPTO's Patent Public Search tool and the Common Citation Document (CCD) to identify prior art cited by various patent offices.

Q: What resources are available for analyzing the global patent family of a specific application?

A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping you identify the global patent family.

Q: How can I understand the economic implications of patent claims?

A: The USPTO's Patent Claims Research Dataset offers detailed information on claims from U.S. patents and applications, which can help in understanding the economic implications.

Q: What is the significance of the small claims patent court study by ACUS?

A: The study by ACUS explores the feasibility of a small claims patent court, which could provide a more accessible and cost-effective way to resolve patent disputes.

Q: Where can I find detailed information on the chemical structures and methods described in United States Patent 10,709,674?

A: The detailed description section of the patent provides elaborate information on the chemical structures and methods of treatment.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. PubChem - Use of cannabinoids in the treatment of epilepsy: https://pubchem.ncbi.nlm.nih.gov/patent/US10709674

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,709,674

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Jazz Pharms Res EPIDIOLEX cannabidiol SOLUTION;ORAL 210365-001 Sep 28, 2018 RX Yes Yes 10,709,674 ⤷  Try for Free USE FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH DRAVET SYNDROME ⤷  Try for Free
Jazz Pharms Res EPIDIOLEX cannabidiol SOLUTION;ORAL 210365-001 Sep 28, 2018 RX Yes Yes 10,709,674 ⤷  Try for Free USE FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH LENNOX-GASTAUT SYNDROME ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,709,674

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom1418171.3Oct 14, 2014

International Family Members for US Patent 10,709,674

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015332212 ⤷  Try for Free
Australia 2021204353 ⤷  Try for Free
Australia 2023258400 ⤷  Try for Free
Brazil 112017007777 ⤷  Try for Free
Canada 2963208 ⤷  Try for Free
Canada 3232241 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.